“The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care” findings published in the July issue of Journal of Managed Care and Specialty Pharmacy, demonstrate the importance of better diagnosis, treatment, and care of individuals with Alzheimer’s, which could lead to more favorable patient outcomes and improved costs for state Medicaid programs and caregivers.
